Latest
Lindt & Sprüngli slashes 2026 revenue growth outlook after European slump
Swiss chocolate maker cuts full-year organic revenue growth forecast to 0-2% from 4-6%, citing consumer price sensitivity and extreme summer heat in Europe.
FINMA closes Signa case, imposes CHF 250m capital add‑on on Julius Bär
Switzerland's financial regulator FINMA concluded its probe into Julius Bär's exposure to the failed Signa group, citing severe breaches and requiring extra capital, a share‑buyback request and ongoing reporting until 2032.
Swiss regulator fines Julius Bär, confiscates ~10 million francs
FINMA closes fifth enforcement case against the private bank, citing grave breaches over Russian PEP accounts and a more-than-1-billion-franc private-debt book tied to former property developer René Benko.
DAX slips 0.13% to 25,374 as US weakness drags German shares
The German DAX closed at 25,374.42 points, down 0.13%, after late‑day losses tied to weak US markets, rising oil and gold prices and concerns over AI sector funding.
Calida lifts dividend and launches 2% share buyback, but analysts stay cautious
Swiss apparel group Calida announced a dividend payout increase to 40‑60% of adjusted earnings and a share repurchase of up to 2% of capital. Analysts say the moves improve returns but urge faster brand investment.
Roche's Pharma Day Targets Fail to Win Over Investors
The Swiss drugmaker unveiled ambitious R&D goals and cost-cutting plans, but shares slipped as investors remained unimpressed with the outlook.
UBS commissions Zurich artist to paint Polybahn car ceilings for 140th anniversary
UBS, owner of the historic Zurich funicular, unveiled a crowd‑sourced mural by artist Fredinko on the ceilings of its two cars, celebrating 140 years of service.
European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares
The Swiss Market Index edged up 0.06% while the DAX and EuroStoxx50 were unchanged; Brent rose to $108 and 10‑year German yields hit 3.65% amid geopolitical risk and AI concerns.
Helvetia Introduces VivaFlex for Flexible Private Pensioning
Swiss insurer Helvetia launches VivaFlex, a new life insurance product designed to adapt to evolving life stages, including part-time work and career transitions.
Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria
Roche outlined a goal of up to 20 new drugs by 2030, introduced a stricter "Bar" framework for candidate selection and highlighted artificial‑intelligence integration across research, aiming for >30 bn CHF sales from top prospects.
BASF probes Evonik, HelloFresh cuts outlook, Airbus reports quality issue
BASF approaches Evonik for a possible deal, HelloFresh lowers its 2024 guidance, Airbus flags a non‑safety quality problem on A321neo jets, and Condor’s ownership shifts to Attestor by 2027.
German fuel prices hit record high as state revenue rises
Super E10 prices averaged 2.286 euros per liter in Germany, driven by regulatory costs and debates over overproduction taxes.
SNB Holds Rates at Zero as Rate-Hike Speculation Stirs
The Swiss National Bank kept its key rate at 0.00% and upgraded its inflation outlook, though economists are divided on when — or if — a rate hike will follow.
Verbio Reports Stronger Q4 Results; Biofuels Producer Skids in Premarket Trade
German biofuels maker Verbio posted fourth-quarter EBITDA of EUR 88.2 million, snapping a year-ago loss, but shares fell 0.8% premarket after full-year guidance missed investor expectations.
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.
Bernstein Downgrades Deutsche Telekom on T-Mobile US Risks; BT Named Top European Telecom Pick
Analysts cut Deutsche Telekom’s valuation amid uncertainty over a potential U.S. merger and German broadband competition, while BT’s outlook improves with Openreach stabilization and reduced capital expenditure.
SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms
Swiss stock market shows slight gains; UBS and Givaudan see increased interest; semiconductor stocks rise; Nestlé underperforms; new ratings and price targets for Swiss stocks
UBS Faces Regulatory Burden, Explores Potential U.S. Mergers Amid Swiss Policy Shift
Swiss regulatory tightening on UBS’s foreign subsidiaries spurs speculation over a potential U.S. acquisition, including with Morgan Stanley, as the bank seeks to mitigate stricter capital requirements.
SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles
Swiss stock market shows resilience, with ABB and UBS gaining while Nestlé lags. Oil prices and bond yields remain key market drivers.
Switzerland ranks 9th in WEF's Travel & Tourism Development Index
The index evaluates the conditions for sustainable and resilient tourism development, not tourism popularity. Japan leads the ranking, followed by the USA and Spain.
SMI climbs as ABB and UBS gain; oil prices fall
Swiss stock market rises, with ABB and UBS among top gainers, while oil prices decline. Analysts warn of rising bond yields.
Swiss Stocks Set for Higher Open on Upgrades, SNB Holds Rates
The SMI looks to open 0.4% higher as UBS upgrades Glencore and analysts revise targets on Swiss shares; the SNB keeps rates at zero percent while oil prices ease.
EU Debates 'Made in Europe' Policy: Switzerland’s Access Remains Uncertain
The European Commission’s proposed Industrial Accelerator Act aims to boost European industry by mandating higher domestic content in public procurement, but definitions of 'Europe' and third-country access vary widely.
EU states split on Swiss access under proposed “Made in Europe” label
Germany backs a “Made with Europe” approach that would include Switzerland, while France and others push for a label limited to the 27 EU members. The dispute centres on the Industrial Accelerator Act and a Dec. 3 deadline.